LMR Partners’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.41K | Hold |
1,881,170
| – | – | ﹤0.01% | 1372 |
|
|
2025
Q4 | $203K | Hold |
1,881,170
| – | – | ﹤0.01% | 1275 |
|
|
2025
Q3 | $391K | Buy |
1,881,170
+270,618
| +17% | +$53.1K | ﹤0.01% | 1129 |
|
|
2025
Q2 | $339K | Buy |
1,610,552
+50,700
| +3% | +$9.79K | ﹤0.01% | 1032 |
|
|
2025
Q1 | $336K | Buy |
1,559,852
+347,104
| +29% | +$115K | ﹤0.01% | 989 |
|
|
2024
Q4 | $497K | Buy |
+1,212,748
| New | +$404K | ﹤0.01% | 839 |
|
|
2024
Q3 | – | Sell |
-1,031,348
| Closed | -$188K | – | 1308 |
|
|
2024
Q2 | $174K | Hold |
1,031,348
| – | – | ﹤0.01% | 864 |
|
|
2024
Q1 | $108K | Hold |
1,031,348
| – | – | ﹤0.01% | 916 |
|
|
2023
Q4 | $361K | Buy |
1,031,348
+200
| +0% | +$57 | ﹤0.01% | 683 |
|
|
2023
Q3 | $237K | Hold |
1,031,148
| – | – | ﹤0.01% | 625 |
|
|
2023
Q2 | $654K | Buy |
1,031,148
+14,300
| +1% | +$6.4K | 0.01% | 466 |
|
|
2023
Q1 | $3.44M | Buy |
1,016,848
+162,000
| +19% | +$100K | 0.05% | 332 |
|
|
2022
Q4 | $3.06M | Buy |
854,848
+191,234
| +29% | +$122K | 0.05% | 387 |
|
|
2022
Q3 | $2.67M | Buy |
663,614
+113,048
| +21% | +$95.8K | 0.05% | 431 |
|
|
2022
Q2 | $2.46M | Buy |
550,566
+45,749
| +9% | +$69.5K | 0.04% | 469 |
|
|
2022
Q1 | $4.29M | Buy |
504,817
+800
| +0.2% | +$1.26K | 0.05% | 349 |
|
|
2021
Q4 | $4.45M | Sell |
504,017
-22,050
| -4% | -$53.9K | 0.05% | 277 |
|
|
2021
Q3 | $5.47M | Buy |
526,067
+302,263
| +135% | +$632K | 0.06% | 235 |
|
|
2021
Q2 | $613K | Buy |
223,804
+65,804
| +42% | +$143K | 0.01% | 634 |
|
|
2021
Q1 | $395K | Buy |
+158,000
| New | +$578K | 0.01% | 687 |
|
|
2020
Q4 | – | Sell |
-333,333
| Closed | -$408K | – | 501 |
|
|
2020
Q3 | $408K | Hold |
333,333
| – | – | 0.01% | 285 |
|
|
2020
Q2 | $300K | Hold |
333,333
| – | – | 0.01% | 448 |
|
|
2020
Q1 | $243K | Buy |
+333,333
| New | +$311K | 0.01% | 212 |
|
Other funds holding SRTAW
VF
WAM
SCM
CS
LMR Partners's SRTAW Position: Q1 2026 in Review
LMR Partners held its Strata Critical Medical Inc Warrants (SRTAW) position steady in Q1 2026 at 1,881,170 shares worth $9.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1372.
LMR Partners first reported a position in SRTAW in Q1 2020 and has held it in 23 quarters since. The position peaked at $5.47M in Q3 2021. 8 funds tracked by Wall St. Rank hold SRTAW as of Q1 2026.
- LMR Partners held 1,881,170 shares of Strata Critical Medical Inc Warrants worth $9.41K as of Q1 2026.
- LMR Partners left its Strata Critical Medical Inc Warrants share count unchanged in Q1 2026.
- Strata Critical Medical Inc Warrants made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1372 holding.
- LMR Partners first reported a position in Strata Critical Medical Inc Warrants in Q1 2020 and has held it in 23 quarters since.
- LMR Partners's Strata Critical Medical Inc Warrants position peaked at $5.47M in Q3 2021.
- 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.